News

Deal Announcements

Conatus Pharma Goes Public For $66 Million

Friday, July 26, 2013 5:58:00 AM PDT | VentureDeal
   San Diego, California  --  Conatus Pharmaceuticals floated its initial public offering (IPO) with gross proceeds of $66 million.

Conatus is developing medicines to treat liver disease, including orphan populations with chronic liver disease and acute exacerbations of chronic liver disease.

The company is backed by a large syndicate of venture capital, private equity and strategic investors.

Proceeds purposes are on file with company statements at the SEC.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1